Unassociated Document PRECISION OPTICS CORPORATION 22 EAST BROADWAY GARDNER, MASSACHUSETTS 01440-3338 Telephone 978 / 630-1800 Telefax 978 / 630-1487 POC:25-0326 Page 1 of 1 NEWS RELEASE FOR IMMEDIATE RELEASE Friday

OPTICS CORPORATION ANNOUNCES ELECTION OF

DIRECTOR AND AUDIT COMMITTEE CHAIR

Optics Corporation, Inc. (Nasdaq: POCI) announced today that Donald A. Major

been elected to the Board of Directors of the Company, to serve as a Class

director to hold office until the annual meeting of stockholders in 2007.

Major was also appointed chairperson of the audit committee and will serve

the audit committee financial expert under Rule 401(e) of Regulation S-B

Nasdaq Marketplace Rule 4350(d)(2).

1, 2005, the Company received a letter from The Nasdaq Stock Market notifying

the Company that it had failed to certify its compliance with the new Audit

Committee composition, Audit and Nominating Committee charter, Executive

Sessions and Code of Conduct Requirements by July 31, 2005, which is a

requirement for continued listing set forth in Nasdaq Marketplace Rule 4350,

that its securities were, therefore, subject to delisting from The Nasdaq

SmallCap Market. As a result of the election of Mr. Major on August 4, 2005,

Company was able to certify its compliance with the new Audit Committee

composition, Audit and Nominating Committee charter, Executive Sessions and

of Conduct Requirements. Nasdaq subsequently sent a letter confirming the

Company's compliance with the rules and indicated that no further action will be

taken on the matter.

Optics Corporation, a leading developer and manufacturer of advanced optical

instruments since 1982, designs and produces high-quality optical thin film

coatings, medical instruments, and other advanced optical systems. The Company's

medical instrumentation line includes laparoscopes, arthroscopes and

endocouplers and a world-class product line of 3-D endoscopes for use in

minimally invasive surgical procedures.

Company is currently developing specialty instruments incorporating its

patent-pending LENSLOCKTM

technology which ensures lower cost, easier repairability and enhanced

durability as well as ultra-small instruments (some with lenses less than

millimeter in diameter) utilizing patent-pending micro-precisionTM

technology. The Company is also exploring new initiatives in single-molecule

technology and nanotechnology for biomedical and other applications.

Optics Corporation is certified to the ISO 9001 Quality Standard, and complies

with the FDA Good Manufacturing Practices and the European Union Medical

Directive for CE Marking of its medical products. The Company's Internet Website

statements contained in this news release, including those related to the

Company's products under development, are made under "safe harbor" provisions of

the Private Securities Litigation Reform Act of 1995 and involve a number

risks and uncertainties that could materially affect future results. These

and uncertainties, many of which are not within the Company's control, include,

but are not limited to, the uncertainty and timing of the successful development

of the Company's new products; the risks associated with reliance on a few key

customers; the Company's ability to maintain compliance with requirements for

continued listing on the NASDAQ SmallCap Market; the Company's ability to

attract and retain personnel with the necessary scientific and technical

the timing and completion of significant orders; the timing and amount of

Company's research and development expenditures; the timing and level of market

acceptance of customers' products for which the Company supplies components;

performance of the Company's vendors; the ability of the Company to control

costs associated with performance under fixed price contracts; and the continued

availability to the Company of essential supplies, materials and services;

the other risk factors and cautionary statements listed from time to time

Company's periodic reports filed with the Securities and Exchange Commission,

including but not limited to, the Company's Annual Report on Form 10-KSB

year ended June 30, 2004.